logo

Onconova Therapeutics, Inc (ONTX)



Trade ONTX now with
  Date
  Headline
9/24/2021 8:35:47 AM Onconova Therapeutics Prices Public Offering Of 5 Mln Shares At $4.20/Shr
6/28/2021 8:28:42 AM Onconova Therapeutics Provides Update On Phase 1/2a Trial Of Rigosertib-Nivolumab Combination In KRAS+ NSCLC
1/7/2021 9:41:44 AM Onconova Therapeutics Reports $8.7 Mln Public Offering
12/21/2020 8:15:22 AM Onconova Report Receipt Of FDA Permission For Phase 1 Study To Proceed Under IND For ON 123300
9/21/2020 8:14:25 AM Onconova Begins Phase 1 Clinical Trial In China For ON 123300 By HanX Biopharmaceuticals
8/31/2020 8:06:32 AM Onconova Therapeutics Names James Marino As Chairman Of Board
8/24/2020 7:33:06 AM Onconova Therapeutics Says Phase 3 INSPIRE Trial Did Not Meet Primary Endpoint Of Improved Survival
7/27/2020 8:15:05 AM Onconova Submits Application For Rigosertib To Participate In Federally Funded Human Studies In COVID-19 Disease